首页> 美国卫生研究院文献>Infection and Immunity >Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein MSP1 in blood-stage infections of naive Aotus monkeys.
【2h】

Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein MSP1 in blood-stage infections of naive Aotus monkeys.

机译:幼虫的血液阶段感染中恶性疟原虫裂殖子表面蛋白MSP1的保守B细胞表位占优势。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have shown that conserved B epitopes were immunodominant in animals hyperimmunized with parasite-purified or recombinant merozoite surface protein MSP1 of Plasmodium falciparum. Cross-priming studies also suggested that a conserved T-helper epitope(s) is efficient in inducing the anti-MSP1 antibody response. In this study, we determined whether a similar profile of immune responses was induced during live P. falciparum infections. Naive Aotus monkeys were infected by blood-stage challenge with either one of the two dimorphic MSP1 alleles represented by the FUP and FVO parasites. Sera collected after parasite clearance were analyzed by enzyme-linked immunosorbent assays (ELISAs). Monkeys infected with parasites carrying one allelic form of MSP1 had antibodies that were equally reactive with homologous or heterologous MSP1s. This preferential recognition of conserved epitopes of MSP1 was confirmed by competitive binding ELISAs. Studies with Plasmodium yoelii and P. falciparum show that the C-terminal 19-kDa fragment of MSP1, MSP1(19), is the target of protective immunity. Thus, monkey sera were assayed for recognition with recombinant MSP1(19)s expressing variant and conserved B epitopes. Results of direct and competitive binding ELISAs showed that the anti-MSP1(19) antibodies were also directed primarily against conserved determinants. The similarities between vaccine- or infection-induced antibody responses suggest a possible reciprocal enhancement of the two populations of anti-MSP1 antibodies when a subunit MSP1 vaccine is introduced into populations living in areas where malaria is endemic. This together with previous observations that conserved determinants are important in MSP1-mediated immunity provides an optimistic outlook that a subunit MSP1 vaccine may be effective and practical for field applications in malaria-exposed populations.
机译:我们已经表明,在用疟原虫恶性疟原虫的寄生虫纯化或重组裂殖子表面蛋白MSP1超免疫的动物中,保守的B表位具有免疫优势。交叉引物研究还表明,保守的T辅助抗原决定簇可有效诱导抗MSP1抗体应答。在这项研究中,我们确定了在恶性疟原虫活感染期间是否诱导了相似的免疫反应。幼稚的Aotus猴子被血期攻击感染了FUP和FVO寄生虫代表的两个双态MSP1等位基因之一。寄生虫清除后收集的血清通过酶联免疫吸附测定(ELISA)进行分析。感染了带有一种等位基因形式的MSP1的寄生虫的猴子所具有的抗体与同源或异源MSP1具有同等的反应性。通过竞争性结合ELISA证实了MSP1保守表位的这种优先识别。对约氏疟原虫和恶性疟原虫的研究表明,MSP1的C端19-kDa片段MSP1(19)是保护性免疫的目标。因此,用表达变体和保守的B表位的重组MSP1(19)s分析了猴血清的识别。直接和竞争结合ELISA的结果表明,抗MSP1(19)抗体也主要针对保守的决定簇。疫苗或感染诱导的抗体反应之间的相似性表明,将MSP1亚单位疫苗引入疟疾流行地区的人群时,两个抗MSP1抗体人群可能会相互增强。这与以前的决定因素在MSP1介导的免疫中很重要的先前观察结果一起,提供了乐观的前景,认为MSP1亚单位疫苗对于在疟疾暴露人群中的野外应用可能是有效和实用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号